Free Trial

1,247 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Bolthouse Investments LLC

UnitedHealth Group logo with Medical background

Bolthouse Investments LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,247 shares of the healthcare conglomerate's stock, valued at approximately $631,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Vulcan Value Partners LLC bought a new position in UnitedHealth Group in the fourth quarter worth about $57,397,000. Boothbay Fund Management LLC grew its stake in UnitedHealth Group by 117.2% during the 4th quarter. Boothbay Fund Management LLC now owns 9,129 shares of the healthcare conglomerate's stock worth $4,618,000 after buying an additional 4,925 shares during the last quarter. Coldstream Capital Management Inc. lifted its stake in UnitedHealth Group by 2.5% in the fourth quarter. Coldstream Capital Management Inc. now owns 27,382 shares of the healthcare conglomerate's stock valued at $13,852,000 after buying an additional 660 shares during the last quarter. Capital Analysts LLC grew its position in shares of UnitedHealth Group by 1.0% during the fourth quarter. Capital Analysts LLC now owns 11,046 shares of the healthcare conglomerate's stock worth $5,587,000 after acquiring an additional 111 shares during the last quarter. Finally, Arnhold LLC lifted its position in UnitedHealth Group by 1.3% in the 4th quarter. Arnhold LLC now owns 44,551 shares of the healthcare conglomerate's stock valued at $22,537,000 after purchasing an additional 555 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent analyst reports. Raymond James reissued a "strong-buy" rating and issued a $540.00 price objective (down from $635.00) on shares of UnitedHealth Group in a report on Monday, April 21st. Mizuho upped their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating on the stock in a research report on Wednesday. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Finally, Hsbc Global Res lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Tuesday. Three analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Buy" and an average price target of $603.05.

Read Our Latest Research Report on UNH

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $418.20 on Friday. UnitedHealth Group Incorporated has a 12 month low of $412.02 and a 12 month high of $630.73. The stock has a market cap of $382.53 billion, a PE ratio of 26.98, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a fifty day simple moving average of $503.28 and a 200-day simple moving average of $535.01.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the company posted $6.91 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.01%. UnitedHealth Group's dividend payout ratio is currently 35.18%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines